[en] Deleterious effect of oral corticosteroids on bone has been well documented, whereas this remains debated for inhaled ones (ICS). Our objectives were to analyze the effects of ICS on bone mineral density, fracture risk and bone markers. We performed an exhaustive systematic research of all controlled trials potentially containing pertinent data, peer-reviewed by a dedicated WHO expert group, and comprehensive meta-analyses of the data. Inclusion criteria were ICS, and BMD/markers/fractures in asthma/chronic obstructive pulmonary diseases (COPD) and healthy patients. Analyses were performed in a conservative fashion using professional dedicated softwares and stratified by outcome, study design and ICS type. Results were expressed as standardized mean difference/effect size (ES), relative risk (RR) or odds ratio (OR), depending on study design and outcome units. Publication bias was investigated. Twenty-three trials were reviewed; 11 papers fit the inclusion criteria and were assessed for the main analysis. Quality scores for the randomized controlled trials (RCTs) were 80%, 71% for the prospective cohort studies, and 78% for the retrospective cohort and cross-sectional studies. We globally assessed ICS effects on BMD and found deleterious effects: ES=0.61 (p=0.001) for healthy subjects, and ES=0.27 (p<0.001) for asthma/COPD patients. For these patients, this effect was 0.21 (p<0.01) at the lumbar spine, and 0.26 (p<0.001) at the hip or femoral neck. A single study evaluated the impact of ICS on hip fracture and reported an increased OR of 1.6 (1.24; 2.03). Lumbar fracture rate differences did not reach the level of statistical significance: 1.87 (0.5; 6.94). Osteocalcin and PICP were decreased and ICTP, pyridinoline and deoxypyridinoline levels were not significantly affected. Budesonide (BUD) appeared to be the ICS inducing the less deleterious effects on bone, followed by beclomethasone dipropionate (BDP) and triamcinolone (TRI). Publication bias investigation provided non-significant results. In our meta-analyses, BUD at a mean daily dose (SD) of 686 mug (158 mug), BDP at 703 mug (123 mug) and TRI at 1000 mug (282 mug) were found to affect bone mineral density and markers in patients suffering from the two major respiratory diseases. These findings could have practical implication in the long-term management of asthmatic and COPD patients.
Disciplines :
Endocrinology, metabolism & nutrition
Author, co-author :
Richy, Florent
Bousquet, Jean
Ehrlich, George E
Meunier, Pierre J
Israel, Elliot
Morii, Hirotoshi
Devogelaer, Jean-Pierre
Peel, Nicola
Haim, Muriel
Bruyère, Olivier ; Université de Liège - ULiège > Département des sciences de la santé publique > Epidémiologie et santé publique
Reginster, Jean-Yves ; Université de Liège - ULiège > Département des sciences de la santé publique > Epidémiologie et santé publique
Language :
English
Title :
Inhaled corticosteroids effects on bone in asthmatic and COPD patients: a quantitative systematic review
Publication date :
March 2003
Journal title :
Osteoporosis International
ISSN :
0937-941X
eISSN :
1433-2965
Publisher :
Springer-Verlag London Ltd, Godalming, United Kingdom
Cushing H (1932) Basophile adenomas. J Nerv Ment Dis 76:50
Curtiss PH, Clark WS, Herndon CH (1954) Vertebral fractures resulting from prolonged cortisone and corticotrophin therapy. J Am Med Assoc 156:467-469
Manolagas SC (2000) Corticosteroids and fractures: a close encounter of the third cell kind. J Bone Miner Res 15:1001-1005
The British Thoracic Society (1998) Guidelines on the management of asthma. Thorax 48:S1-S24
Walsh LJ, Wong CA, Cooper S, Guhan AR, Pringle M, Tattersfield AE (1999) Morbidity from asthma in relation to regular treatment: a community based study. Thorax 54:296-300
National Asthma Education and Prevention Program (1997) Expert panel report 2: guidelines for the diagnosis and management of asthma. National Heart Lung and Blood Institute, NIH publication no. 97:4051, Bethesda, Maryland
NHLBI/WHO workshop report (1995) Global strategy for asthma management and prevention: global initiative for asthma. National Heart, Lung, and Blood Institute NIH publication no. 95:3659, Bethesda, Maryland
Dickersin K, Scherer R, Lefebvre C (1994) Identifying the relevant studies for systematic reviews. Br Med J 309:1286-1291
Jadad AR, Moore RA, Carroll D, Jenkinson C (1996) Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials 17:1-12
Egger M, Smith GD, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. Br Med J 315:629-634
Hanania NA, Chapman KR (1996) Dose-related decrease in bone density among asthmatic patients treated with inhaled corticosteroids. J Allergy Clin Immunol 5:571-579
Israel E, Banerjee TR, Fitzmaurice GM, Kotlvov TV, LaHive K, LeBoff MS (2001) Effects of inhaled glucocorticoids on bone density in premenopausal women. N Engl J Med 345:941-947
Kerstjens HA, Postma DS, van Doormaal JJ, van Zanten AK, Brand PL, Dekhuijzen PN et al. (1994) Effects of short-term and long-term treatment with inhaled corticosteroids on bone metabolism in patients with airways obstruction. Dutch CNSLD Study Group. Thorax 49:652-656
Li JTC, Ford LB, Chervinsky P, Weisberg SC, Kellerman DJ, Faulkner KG et al. (1999) Fluticasone propionate powder and lack of clinically significant effects on hypothalamic-pituitary-adrenal axis and bone mineral density over 2 years in adults with mild asthma. J Allergy Clin Immunol 103:1062-1068
McEvoy CE, Ensrud KE, Bender E, Genant HK, Yu W, Griffith JM et al. (1998) Association between corticosteroid use and vertebral fractures in older men with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157:704-709
Pauwels RA, Löfdahl CG, Laitinen LA, Schouten JP, Postma DS, Pride NB et al. (1999) Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. N Engl J Med 340:1948-1953
Struijs A, Mulder H (1997) The effects of inhaled glucocorticoids on bone mass and biochemical markers of bone homeostasis: a 1-year study of beclomethasone dipropionate. Nederlands J Med 50:233-237
Tattersfield AE, Town GI, Johnell O, Picado C, Aubier M, Braillon P, Karlström R (2001) Bone mineral density in subjects with mild asthma randomized to treatment with inhaled corticosteroids or non-corticosteroid treatment for two years. Thorax 56:272-278
The Lung Health Study Research Group (2000) Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease. N Engl J Med 343:1902-1909
Van Staa TP, Leufkens HG, Cooper C (2001) Use of inhaled corticosteroids and risk of fractures. J Bone Miner Res 16:581-588
Wisniewski AF, Lewis AS, Green DJ, Maslanka W, Burrell H, Tattersfield AE (1997) Cross-sectional investigation of the effects of inhaled corticosteroids on bone density and bone metabolism in patients with asthma. Thorax 52:853-860
Baxter-Jones AD, Helms PJ, Russell G, Grant A, Ross S, Cairns JA et al. (2000) Early asthma prophylaxis, natural history, skeletal development and economy (EASE): a pilot randomised controlled trial. Health Technol Assess 4:28
Toogood JH, Jennings B, Hodsman AB, Baskerville J, Fraher LJ (1991) Effects of dose and schedule of inhaled budesonide on bone turniver. J Allergy Clin Immunol 88:572-579
Hodsman AB, Toogood JH, Jennings B, Fraher LJ, Baskerville JC (1991) Differential effects of inhaled budesonide and oral prednisolone on serum osteocalcin. J Clin Endocrinol Metab 72:530-540
Paggiaro PL, Dahle D, Bakran I, Frith L, Hollingworth K, Efthimiou J et al. (1998) Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. Lancet 351:773-780
Leech JA, Hodder RV, OOI DS, Gay J (1993) Effects of short-term inhaled budesonide and beclomethasone dipropionate on serum osteocalcin in premenopausal women. Am Rev Respir Dis 148:113-115
Fujita K, Kasayama S, Hashimoto J, Nagasaka Y, Nakano N, Morimoto Y et al. (2001) Inhaled corticosteroids reduce bone mineral density in early postmenopausal but not premenopausal asthmatic women. J Bone Min Res 16:782-787
Herrala J, Puolijoki H, Impivaara O, Liippo K, Tala E, Nieminen MM (1994) Bone mineral density in asthmatic women on high-dose inhaled beclomethasone dispropionate. Bone 15:621-623
Egan JJ, Maden C, Kalra S, Adams JE, Eastell R, Woodcock AA (1999) A randomized, double-blind study comparing the effects of beclomethasone and fluticasone on bone density over two years. Eur Respir J 13:1267-1275
Luengo M, del Rio L, Pons F, Picado C (1997) Bone mineral density in asthmatic patients treated with inhaled corticosteroids: a case-control study. Eur Respir J 10:2110-2113
Boulet LP, Giguère MC, Milot JM, Brown J (1994) Effects of long-term use of high-dose inhaled steroids on bone density and calcium metabolism. J Allergy Clin Immunol 94:796-802
Ip M, Lam K, Yam L, Kung A, Ng M (1994) Decreased bone mineral density in premenopausal asthma patients receiving long-term inhaled steroids. Chest 105:1722-1727
Harris M, Hauser S, Nguyen TV, Kelly PJ, Rodda C, Morton J (2001) Bone mineral density in prepubertal asthmatics receiving corticosteroid treatment. J Paediatr Child Health 37:67-71
Jones A, Fay JK, Burr M, Stone M, Hood K, Roberts G (2002) Inhaled corticosteroid effect on bone metabolism in asthma and mild chronic obstructive pulmonary disease (Cochrane Review). Cochrane Database Syst Rev:CD003537
Lipworth BJ (1999) Systemic adverse effects of inhaled corticosteroid therapy. Arch Intern Med 159:941-955
Devogelaer JP, Crabbe J, Nagant de Deuxchaisnes C (1987) Bone mineral density in Addison's disease: evidence for an effect of adrenal androgens on bone mass. Br Med J 294:798-800
Bruyere O, Stephaniak N, Reginster JY (2002) Biochemical markers in glucocorticoid-induced osteoporosis. In: Giustina A, Angeli A, Canalis E, Manelli F (eds) Glucocorticoid-induced osteoporosis. Frontiers in Hormonal Research, Karger, Basel, vol 30, pp 49-59
Sasaki N, Kusano E, Ando Y, Yano K, Tsuda E, Asano Y (2001) Glucocorticoid decreases circulating osteoprotegerin (OPG): possible mechanism for glucocorticoid induced osteoporosis. Nephrol Dial Transplant 16:479-482
Reid DM, Nicoll JJ, Smith MA, Higgins B, Tothill P, Nuki G (1986) Corticosteroids and bone mass in asthma: comparisons with rheumatoid arthritis and polymyalgia rheumatica. Br Med J 293:1463-1466
Riancho JA, Gonzales MJ, del Arco C, Amado JA, Freijanes J, Anton MA (1987) Vertebral compression fractures and mineral metabolism in chronic obstructive luna disease. Thorax 42:962-966
Praet JP, Peretz A, Rozenberg S, Famaey JP, Bourdoux P (1992) Risk of osteoporosis in men with chronic bronchitis. Osteoporos Int 2:257-261